The Catalan Ministry of Health, Catalan Institute of Health, researchers at Germans Trias i Pujol Hospital and pharmaceutical corporations Gebro Pharma and Laboratorios Rubio, both CataloniaBio & HealthTech members, have kicked off the first clinical trial in the world to treat and control the Covid-19 pandemic.

The study is giving one antiretroviral drug to people who have tested positive for Covid-19 and another to people in contact with them. It will be tested on nearly 3,000 people and preliminary results are expected this April.

The project is led by renowned epidemiologist Oriol Mitjà of Germans Trias i Pujol Hospital and the Fight AIDS Foundation.

More information (in Spanish)

Recently, Qiagen has launched a quick diagnostic test for SARS-CoV-2 (QIAstat-Dx) developed from the technology of Catalan company STAT-Dx. 

Photo: Dr Oriol Mitjà, Catalan Minister Alba Vergés, Director General for Research Robert Fabregat and AQuAs Director César Velasco at the press conference - © Generalitat de Catalunya

Collaborate in the fight against Covid-19